INMED LLC.

In News

INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

Business Wire - May 19, 2026

InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares - Stock Titan

Stock Titan - Aug 14, 2026

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - TMX Newsfile

TMX Newsfile - Jul 06, 2026

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Investing News Network

Investing News Network - Mar 06, 2026

Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders? - TradingView

TradingView - Jun 12, 2026

/C O R R E C T I O N -- InMed Pharmaceuticals/ - PR Newswire

PR Newswire - May 20, 2026

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) - GlobeNewswire

GlobeNewswire - May 19, 2026

Are ESI, INM, HUN, OLN Obtaining Fair Deals for their Shareholders? - TradingView

TradingView - Jul 06, 2026

InMed Provides Update on BayMedica Commercial Business - Investing News Network

Investing News Network - Dec 12, 2025

InMed Pharmaceuticals Secures $5M in Private Placement - TipRanks

TipRanks - Jun 30, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment